Article

Corneal transplants use pre-loaded tissue

Cartridges pre-loaded by an eye bank (EndoGlide, Angiotech Pharmaceuticals Inc.) have been successfully used in corneal transplantation.

 

Tampa, FL-Cartridges pre-loaded by an eye bank (EndoGlide, Angiotech Pharmaceuticals Inc.) have been successfully used in corneal transplantation, according to the Lions Eye Institute for Transplant & Research (LEITR).

The cartridges were selected for initial endothelial keratoplasty transplant procedures utilizing donor endothelial tissue that was pre-cut, trephined, and pre-loaded into the device at LEITR in Tampa, FL.

The loaded cartridges were then transported to the Massachusetts Eye and Ear Infirmary, Boston, where the procedures were performed by Roberto Pineda II, MD, associate professor of ophthalmology at Harvard Medical School.

“Tissue preparation and device pre-loading by eye banks not only simplifies the surgery [but] may provide increased reproducible outcomes for endothelial keratoplasty,” said Dr. Pineda.

In a pre-clinical study presented at the 2012 Association for Research in Vision and Ophthalmology (ARVO) annual meeting, LEITR reported that eye banks are able to prepare and load corneal tissue safely into the cartridges; corneal buttons pre-loaded by LEITR sustained an average of 9.07% endothelial cell damage, compared with 36.2% in control group tissue that was loaded into the insertion system on site, a statistically significant difference (p = 0.004).

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
© 2025 MJH Life Sciences

All rights reserved.